Literature DB >> 23885713

Permeability of the anterior lens capsule for large molecules and small drugs.

Christian Kastner1, Marian Löbler, Katrin Sternberg, Thomas Reske, Oliver Stachs, Rudolf Guthoff, Klaus-Peter Schmitz.   

Abstract

PURPOSE: For developing injectable lenses the retention properties of the capsular bag are important. Therefore the apparent permeability coefficients of sodium fluorescein and fluorescent dextrans of different sizes were determined for the human anterior lens capsule to calculate a molecular weight cutoff from these data. In addition, permeability coefficients of drugs helpful for the suppression of secondary cataract were determined.
MATERIALS AND METHODS: Capsulorhexis specimens were fixed in a specially designed two compartment diffusion chamber to investigate the permeation of sodium fluorescein and fluorescent dextrans of different sizes (10, 40, 70 and 150 kDa) for 24 h (n ≥ 3) and of the antiproliferative drugs actinomycin D and methotrexate for 0.5, 24, 48 and 72 h (n ≥ 3).
RESULTS: The molecular weight cutoff of the anterior lens capsule was found to be 166 ± 82 kDa. After 0.5 h, no passage of actinomycin D and methotrexate was detectable through the lens capsule. The apparent permeability coefficients for actinomycin D and methotrexate were calculated to 0.71 ± 0.02 µm/s and to 0.80 ± 0.13 µm/s, respectively.
CONCLUSIONS: The capsular bag retains fluorescent dextrans with a molecular weight of >166 kDa. Hence, prepolymers are required to polymerize rapidly to be retained inside of the capsular bag. In addition, low-molecular substances intended as antiproliferative drugs for secondary cataract prevention should be applied within a time frame of five minutes in such a way that cells adjacent to the capsular bag will not be damaged.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23885713     DOI: 10.3109/02713683.2013.803288

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  6 in total

1.  Objective evaluation of changes in lens clarity after repeated injections of ranibizumab in patients with neovascular age-related macular degeneration.

Authors:  Orhan Altunel; Saadet Gültekin Irgat; Fatih Özcura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-21       Impact factor: 3.535

2.  Impact of Subunit Composition on the Uptake of α-Crystallin by Lens and Retina.

Authors:  Niklaus H Mueller; Uma Fogueri; Michelle G Pedler; Kameron Montana; J Mark Petrash; David A Ammar
Journal:  PLoS One       Date:  2015-09-10       Impact factor: 3.240

3.  Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells.

Authors:  Jong Hwa Jun; Wern-Joo Sohn; Youngkyun Lee; Jae-Young Kim
Journal:  Clin Ophthalmol       Date:  2016-06-27

4.  Distribution of Small Molecular Weight Drugs into the Porcine Lens: Studies on Imaging Mass Spectrometry, Partition Coefficients, and Implications in Ocular Pharmacokinetics.

Authors:  Emma M Heikkinen; Seppo Auriola; Veli-Pekka Ranta; Nicholas J Demarais; Angus C Grey; Eva M Del Amo; Elisa Toropainen; Kati-Sisko Vellonen; Arto Urtti; Marika Ruponen
Journal:  Mol Pharm       Date:  2019-08-08       Impact factor: 4.939

5.  Changes in Surface Tension of Aqueous Humor in Anterior Segment Ocular Pathologies.

Authors:  Javier Cabrerizo; J Haritz Urcola; Elena Vecino
Journal:  Vision (Basel)       Date:  2016-09-20

6.  Age-dependency of molecular diffusion in the human anterior lens capsule assessed using fluorescence recovery after photobleaching.

Authors:  Vivian M Sueiras; Floriane Devaux; Benjamin Smith; James Lai; Wyndham Batchelor; Nikita Y Likht; Vincent T Moy; Noël M Ziebarth
Journal:  Mol Vis       Date:  2019-10-14       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.